Mediwhale
Seoul, South KoreaWebsite
Mediwhale is an AI-powered health diagnostic company that uses retinal image analysis to provide SaaS-based cardiovascular and kidney disease risk assessments.
1open role
Loading company information...
Mediwhale is an AI-powered health diagnostic company that uses retinal image analysis to provide SaaS-based cardiovascular and kidney disease risk assessments.
Company context
Mediwhale prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Mediwhale is a pioneering South Korean HealthTech company that specializes in AI-powered, non-invasive diagnostic software. By leveraging deep learning to analyze retinal images, the company provides Software as a Medical Device (SaMD) solutions that assess risks for cardiovascular and chronic kidney diseases. Their flagship product suite, Dr. Noon, transforms standard retinal photographs into powerful diagnostic tools, enabling early detection and preventive care that is both accessible and highly accurate.
Mediwhale’s mission is to bridge the healthcare gap by making preventive care accessible, affordable, and effective through advanced retinal AI scans, facilitating early detection and personalized health assessments to prevent life-threatening cardiovascular and metabolic diseases.
Founded
2016
Headquarters
Seoul, South Korea
Employees
50-200
Industry
HealthTech / SaaS
Opportunity to work on cutting-edge, life-saving medical AI technology
Strong clinical validation and scientific rigor behind the product
High pressure associated with regulatory compliance and medical device standards
Rapid scaling and international expansion can lead to fast-paced, demanding workflows
Revenue
Undisclosed
Funding
Series C ($15M+ USD)
CEO
Kevin Choi